Lv5
1230 积分 2022-04-30 加入
The Landmark Series: The Future of Pancreatic Cancer Clinical Trials
2天前
已完结
Treatment of metastatic pancreatic cancer: 25 years of innovation with little progress for patients
2天前
已完结
Evaluation of Pancreatic Cancer Clinical Trials and Benchmarks for Clinically Meaningful Future Trials
3天前
求助中
Evaluation of Pancreatic Cancer Clinical Trials and Benchmarks for Clinically Meaningful Future Trials
3天前
已关闭
Clinicopathologic characteristics, co-mutation landscape, and survival outcomes of KRAS-G12D mutant lung adenocarcinoma in comparison to KRAS-G12C and EGFR-mutated subtypes
3天前
已完结
Plinabulin plus docetaxel versus docetaxel in patients with non-small-cell lung cancer after disease progression on platinum-based regimen (DUBLIN-3): a phase 3, international, multicentre, single-blind, parallel group, randomised controlled trial
11天前
已完结
Late-line options for patients with metastatic colorectal cancer: a review and evidence-based algorithm
20天前
已完结
Implications of EGFR expression on EGFR signaling dependency and adaptive immunity against EGFR-mutated lung adenocarcinoma
21天前
已完结
Rapid non-uniform adaptation to conformation-specific KRAS(G12C) inhibition
23天前
已完结
Targeting the EGFR signalling pathway in metastatic colorectal cancer
23天前
已完结
皖公网安备34019202002308
